VACCINIA RECOMBINANT EXPRESSING LASSA-VIRUS INTERNAL NUCLEOCAPSID PROTEIN PROTECTS GUINEAPIGS AGAINST LASSA FEVER
- 1 July 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 330 (8552) , 186-188
- https://doi.org/10.1016/s0140-6736(87)90767-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A Prospective Study of the Epidemiology and Ecology of Lassa FeverThe Journal of Infectious Diseases, 1987
- Purified Influenza Virus Nucleoprotein Protects Mice from Lethal InfectionJournal of General Virology, 1987
- Vaccinia Virus Expression VectorsJournal of General Virology, 1986
- Molecular cloning of Lassa virus RNA: Nucleotide sequence and expression of the nucleocapsid protein geneVirology, 1985
- Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1985
- General method for production and selection of infectious vaccinia virus recombinants expressing foreign genesJournal of Virology, 1984
- Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- ISOLATED CASE OF LASSA FEVER IN ZARIA, NORTHERN NIGERIAThe Lancet, 1980
- Lassa fever in Panguma Hospital, Sierra Leone, 1973-6.BMJ, 1977